Global Swine Healthcare Market Analysis, 2012-2016 and Forecast, 2017 - 2023
Global Swine Healthcare Market: By Product Type (Drugs, Feed Products),By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections), By Route of Administration (Oral, Parenteral), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market Outline: Swine Healthcare Market
Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases.
Market Dynamics: Swine Healthcare Market
Drivers
Increase in the demand for healthy pork meat coupled with rise in number of pork meat industries
Rise in prevalence of various infectious and foodborne diseases
Increase in the R&D activities for the innovation of novel therapeutics and feed products
Restraints
Stringent regulatory guidelines for the swine vaccines and drug approvals
Lack of awareness about the swine diseases in the veterinary professionals
Adverse effects associated with the drugs and lack of awareness about medicated and nutrient feed in underdeveloped countries
Market Scope: Swine Healthcare Market
Global swine healthcare market is segmented on the basis of Product type, disease type, route of administration, distribution channel, and region
Based on the product type, swine healthcare market is segmented into the following:
Drugs
Vaccines
Antibiotics
Antifungals
Parasiticides
Anti-Viral Drugs
Others
Feed Products
Nutritional Feed
Medicated Feed
Non-Medicated Feed
Based on the disease type, swine healthcare market is segmented into the following:
Viral Infections
Bacterial Infections
Parasitic Infection
Fungal Infections
Based on the route of administration, swine healthcare market is segmented into the following:
Oral
Parenteral
Based on the distribution channel,swine healthcare market is segmented into the following:
Veterinary Hospitals
Veterinary Pharmacies
Online Pharmacies
Based on the region, swine healthcare market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competition Assessment: Swine Healthcare Market
Some of the players in the global swine healthcare market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Virbac S.A. (France)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Ceva Sante Animale (France)
Wilbur-Ellis Feed, LLC (U.S.)
Vetoquinol S.A. (France)
Notable Market Developments:Swine Healthcare Market
In January 2017, Ceva Sante Animale acquired Merial swine and cattle vaccine and NSAIDs portfolio from Boehringer Ingelheim
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies and regulatory framework
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Market Outline: Swine Healthcare Market
Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases.
Market Dynamics: Swine Healthcare Market
Drivers
Increase in the demand for healthy pork meat coupled with rise in number of pork meat industries
Rise in prevalence of various infectious and foodborne diseases
Increase in the R&D activities for the innovation of novel therapeutics and feed products
Restraints
Stringent regulatory guidelines for the swine vaccines and drug approvals
Lack of awareness about the swine diseases in the veterinary professionals
Adverse effects associated with the drugs and lack of awareness about medicated and nutrient feed in underdeveloped countries
Market Scope: Swine Healthcare Market
Global swine healthcare market is segmented on the basis of Product type, disease type, route of administration, distribution channel, and region
Based on the product type, swine healthcare market is segmented into the following:
Drugs
Vaccines
Antibiotics
Antifungals
Parasiticides
Anti-Viral Drugs
Others
Feed Products
Nutritional Feed
Medicated Feed
Non-Medicated Feed
Based on the disease type, swine healthcare market is segmented into the following:
Viral Infections
Bacterial Infections
Parasitic Infection
Fungal Infections
Based on the route of administration, swine healthcare market is segmented into the following:
Oral
Parenteral
Based on the distribution channel,swine healthcare market is segmented into the following:
Veterinary Hospitals
Veterinary Pharmacies
Online Pharmacies
Based on the region, swine healthcare market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competition Assessment: Swine Healthcare Market
Some of the players in the global swine healthcare market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Virbac S.A. (France)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Ceva Sante Animale (France)
Wilbur-Ellis Feed, LLC (U.S.)
Vetoquinol S.A. (France)
Notable Market Developments:Swine Healthcare Market
In January 2017, Ceva Sante Animale acquired Merial swine and cattle vaccine and NSAIDs portfolio from Boehringer Ingelheim
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies and regulatory framework
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. EXECUTIVE SUMMARY
2. GLOBAL SWINE HEALTHCARE MARKET INTRODUCTION
2.1. Global Swine Healthcare Market – Taxonomy
2.2. Global Swine Healthcare Market –Definitions
2.2.1. Product Type
2.2.2. Disease Type
3. GLOBAL SWINE HEALTHCARE MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Swine Healthcare Market Dynamic Factors - Impact Analysis
3.6. Global Swine Healthcare Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL SWINE HEALTHCARE MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL SWINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Vaccines
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antibiotics
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antifungals
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Parasiticides
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Anti-viral Drugs
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Nutritional Feed
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Medicated Feed
5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Non-Medicated Feed
5.8.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY DISEASE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Viral Infections
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Bacterial Infections
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Parasitic Infection
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Parasitic Infection
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Oral
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Veterinary Hospitals
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. North America
9.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Region, 2017 – 2023
10. NORTH AMERICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Drugs
10.1.1.1. Vaccines
10.1.1.2. Antibiotics
10.1.1.3. Antifungals
10.1.1.4. Parasiticides
10.1.1.5. Anti-Viral Drugs
10.1.1.6. Others
10.1.2. Feed Products
10.1.2.1. Nutritional Feed
10.1.2.2. Medicated Feed
10.1.2.3. Non-Medicated Feed
10.2. Disease Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Viral Infections
10.2.2. Bacterial Infections
10.2.3. Parasitic Infection
10.2.4. Fungal Infections
10.3. Route of Administration Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Others
10.4. Distribution Channel Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Veterinary Hospital
10.4.2. Veterinaty Pharmacies
10.4.3. Online Pharmaceis
10.5. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
10.7. North America Swine Healthcare Market Dynamics – Trends
11. EUROPE SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Germany
11.1.2. UK
11.1.3. France
11.1.4. Spain
11.1.5. Italy
11.1.6. Russia
11.1.7. Poland
11.1.8. Rest of Europe
11.2. Europe Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
11.3. Europe Swine Healthcare Market Dynamics – Trends
12. ASIA-PACIFIC SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Japan
12.1.2. China
12.1.3. India
12.1.4. ASEAN
12.1.5. Australia & New Zealand
12.1.6. Rest of Asia-Pacific
12.2. Asia-Pacific Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
12.3. Asia-Pacific Swine Healthcare Market Dynamics – Trends
13. LATIN AMERICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Argentina
13.1.4. Venezuela
13.1.5. Rest of Latin America
13.2. Latin America Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
13.3. Latin America Swine Healthcare Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
14.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.1.1. Gulf Cooperation Council (GCC) Countries
14.1.2. Israel
14.1.3. South Africa
14.1.4. Rest of MEA
14.2. MEA Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
14.3. MEA Swine Healthcare Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis (Pfizer, Inc.) (U.S.)
15.2.2. Merck & Co. Inc. (U.S)
15.2.3. Virbac S.A. (France)
15.2.4. Boehringer Ingelheim Vetmedica (Germany)
15.2.5. Elanco (U.S.)
15.2.6. Bayer Animal Health (Germany)
15.2.7. Ceva Sante Animale (France)
15.2.8. Wilbur-Ellis Feed, LLC (U.S.)
15.2.9. Vetoquinol S.A. (France)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL SWINE HEALTHCARE MARKET INTRODUCTION
2.1. Global Swine Healthcare Market – Taxonomy
2.2. Global Swine Healthcare Market –Definitions
2.2.1. Product Type
2.2.2. Disease Type
3. GLOBAL SWINE HEALTHCARE MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Swine Healthcare Market Dynamic Factors - Impact Analysis
3.6. Global Swine Healthcare Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL SWINE HEALTHCARE MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL SWINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Vaccines
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antibiotics
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antifungals
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Parasiticides
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Anti-viral Drugs
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Nutritional Feed
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Medicated Feed
5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Non-Medicated Feed
5.8.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY DISEASE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Viral Infections
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Bacterial Infections
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Parasitic Infection
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Parasitic Infection
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 – 2023
7.1. Oral
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023
8.1. Veterinary Hospitals
8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL SWINE HEALTHCARE MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. North America
9.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Region, 2017 – 2023
10. NORTH AMERICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Product Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Drugs
10.1.1.1. Vaccines
10.1.1.2. Antibiotics
10.1.1.3. Antifungals
10.1.1.4. Parasiticides
10.1.1.5. Anti-Viral Drugs
10.1.1.6. Others
10.1.2. Feed Products
10.1.2.1. Nutritional Feed
10.1.2.2. Medicated Feed
10.1.2.3. Non-Medicated Feed
10.2. Disease Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Viral Infections
10.2.2. Bacterial Infections
10.2.3. Parasitic Infection
10.2.4. Fungal Infections
10.3. Route of Administration Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Others
10.4. Distribution Channel Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Veterinary Hospital
10.4.2. Veterinaty Pharmacies
10.4.3. Online Pharmaceis
10.5. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
10.7. North America Swine Healthcare Market Dynamics – Trends
11. EUROPE SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Germany
11.1.2. UK
11.1.3. France
11.1.4. Spain
11.1.5. Italy
11.1.6. Russia
11.1.7. Poland
11.1.8. Rest of Europe
11.2. Europe Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
11.3. Europe Swine Healthcare Market Dynamics – Trends
12. ASIA-PACIFIC SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Japan
12.1.2. China
12.1.3. India
12.1.4. ASEAN
12.1.5. Australia & New Zealand
12.1.6. Rest of Asia-Pacific
12.2. Asia-Pacific Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
12.3. Asia-Pacific Swine Healthcare Market Dynamics – Trends
13. LATIN AMERICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
13.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Argentina
13.1.4. Venezuela
13.1.5. Rest of Latin America
13.2. Latin America Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
13.3. Latin America Swine Healthcare Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA SWINE HEALTHCARE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
14.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.1.1. Gulf Cooperation Council (GCC) Countries
14.1.2. Israel
14.1.3. South Africa
14.1.4. Rest of MEA
14.2. MEA Swine Healthcare Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country, 2017 – 2023
14.3. MEA Swine Healthcare Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis (Pfizer, Inc.) (U.S.)
15.2.2. Merck & Co. Inc. (U.S)
15.2.3. Virbac S.A. (France)
15.2.4. Boehringer Ingelheim Vetmedica (Germany)
15.2.5. Elanco (U.S.)
15.2.6. Bayer Animal Health (Germany)
15.2.7. Ceva Sante Animale (France)
15.2.8. Wilbur-Ellis Feed, LLC (U.S.)
15.2.9. Vetoquinol S.A. (France)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
